CD4+ and CD8+ cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma

Introduction: This study aimed to analyse cervical lymphocytic populations in HIV+ and HIV− patients and correlate different cervical lesions with HIV viral load and presence of high-risk HPV types. Material and methods: A total of 132 histological specimens from 40 HIV+ and 72 HIV− patients were ev...

Full description

Bibliographic Details
Main Authors: Maria José Brito, Pedro Sequeira, Iryna Silva, Ana Quintas, Catarina Martins, Ana Félix
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
HIV
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220322888
Description
Summary:Introduction: This study aimed to analyse cervical lymphocytic populations in HIV+ and HIV− patients and correlate different cervical lesions with HIV viral load and presence of high-risk HPV types. Material and methods: A total of 132 histological specimens from 40 HIV+ and 72 HIV− patients were evaluated for CD4+ and CD8+ T cell distribution, presence of high-risk HPV types, peripheral blood HIV viral load and CD4+/CD8+ ratio. Results: High-grade squamous intraepithelial lesions (HSIL) and squamous cell carcinoma (SCC) from HIV+ patients had lower CD4+ T cell scores compared with HIV− patients. In all lesion groups, HIV+ patients presented higher epithelial and stromal CD8+ T cell scores. HIV viral load was more often detectable in patients with SCC than in those with low-grade squamous intraepithelial lesion (LSIL) (p = 0.0409). HSIL HIV+ patients had lower circulating CD4+ T cell counts (p = 0.0434) and CD4+/CD8+ ratio (p = 0.0378) compared with LSIL HIV+ patients. High-risk HPV types other than 16 and 18/45 were more prevalent in the HIV+ group. Discussion: These results support an imbalance between cervical CD4+ and CD8+ T lymphocytes of HIV+ patients with SIL and SCC, with increased CD8+ infiltrate density with lesion severity, even in patients with immune system recovery under cART.
ISSN:1201-9712